50.40

1.49% 0.74

After Hours: 50.40

Prestige Consumer Healthcare Inc (PBH)

Overview News Price History Option Chain Financials Discussions Forecast

Prestige Consumer Healthcare Inc stock is traded at $50.40, with a volume of 435.64K. It is up +1.49% in the last 24 hours and up +2.00% over the past month. Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Previous Close:

$49.66

Open:

$50.36

24h Volume:

435.64K

Relative Volume:

0.63

Market Cap:

$2.39B

Revenue:

$1.10B

Net Income/Loss:

$186.50M

P/E Ratio:

13.33

EPS:

3.7817

Net Cash Flow:

$267.19M

1W Performance:

-0.02%

1M Performance:

+2.00%

6M Performance:

-21.13%

1Y Performance:

-34.44%

1-Day Range:

$49.58

$51.28

1-Week Range:

$48.25

$51.28

52-Week Range:

$42.62

$77.03

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Name

Prestige Consumer Healthcare Inc

Sector

Healthcare (1074)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

(914) 524-6800

Address

660 WHITE PLAINS RD., TARRYTOWN, NY

Employee

890

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

PBH's Discussions on Twitter

Compare PBH vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBH Prestige Consumer Healthcare Inc	50.40	2.35B	1.10B	186.50M	267.19M	3.7817
TAK Takeda Pharmaceutical Co Adr	17.44	55.06B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.94	43.07B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.08	35.88B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.92	31.59B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	527.94	26.32B	3.17B	1.29B	1.01B	27.09

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Upgrade	Sidoti	Neutral → Buy
Dec-09-24	Downgrade	Sidoti	Buy → Neutral
Jun-21-24	Upgrade	DA Davidson	Neutral → Buy
Nov-17-22	Initiated	Canaccord Genuity	Buy
May-10-22	Upgrade	Jefferies	Hold → Buy
May-09-22	Upgrade	Oppenheimer	Perform → Outperform
Aug-07-20	Downgrade	DA Davidson	Buy → Neutral
Jun-29-20	Upgrade	Sidoti	Neutral → Buy
Apr-14-20	Downgrade	Jefferies	Buy → Hold
Apr-07-20	Resumed	Sidoti	Neutral
Mar-26-20	Upgrade	Jefferies	Hold → Buy
Mar-24-20	Initiated	Oppenheimer	Perform
Mar-19-20	Upgrade	DA Davidson	Neutral → Buy
Jan-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-04-17	Upgrade	William Blair	Mkt Perform → Outperform
Jun-02-17	Upgrade	Jefferies	Underperform → Hold
May-22-17	Upgrade	Raymond James	Mkt Perform → Outperform
Dec-27-16	Reiterated	B. Riley & Co.	Buy
Nov-17-16	Initiated	Gabelli & Co	Buy
Aug-12-16	Upgrade	Sidoti	Neutral → Buy
Mar-08-16	Initiated	KeyBanc Capital Mkts	Overweight
Feb-05-16	Initiated	Piper Jaffray	Overweight
Nov-30-15	Downgrade	Jefferies	Hold → Underperform
Apr-28-14	Reiterated	B. Riley & Co.	Buy
Apr-28-14	Reiterated	Oppenheimer	Outperform
Jul-09-13	Initiated	B. Riley & Co.	Buy

View All

Prestige Consumer Healthcare Inc Stock (PBH) Latest News

05:22 AM

Prestige Consumer Healthcare (PBH) Stock Analysis: Uncovering a 34.51% Potential Upside - DirectorsTalk Interviews

05:22 AM

02:27 AM